VivoSim Labs, Inc. (NASDAQ:VIVS) Short Interest Up 485.2% in September

VivoSim Labs, Inc. (NASDAQ:VIVS) saw a significant increase in short interest during the month of September. As of September 15th, there was short interest totaling 221,800 shares, an increase of 485.2% from the August 31st total of 37,900 shares. Based on an average daily trading volume, of 312,000 shares, the days-to-cover ratio is presently 0.7 days. Approximately 8.6% of the shares of the company are sold short. Approximately 8.6% of the shares of the company are sold short. Based on an average daily trading volume, of 312,000 shares, the days-to-cover ratio is presently 0.7 days.

VivoSim Labs Stock Performance

Shares of VivoSim Labs stock opened at $3.46 on Friday. VivoSim Labs has a 1 year low of $1.41 and a 1 year high of $21.96. The business has a fifty day moving average of $2.58. The firm has a market capitalization of $9.00 million, a P/E ratio of -0.34 and a beta of 1.13.

VivoSim Labs (NASDAQ:VIVS) last released its earnings results on Tuesday, August 12th. The company reported ($1.14) EPS for the quarter. The company had revenue of $0.04 million for the quarter. VivoSim Labs had a negative net margin of 1,396.48% and a negative return on equity of 32.95%.

About VivoSim Labs

Organovo Holdings, Inc, a biotechnology company, focuses on developing 3D tissues that recapitulate key aspects of human disease. Its 3D human tissue platform includes its proprietary NovoGen Bioprinters, which are automated devices that enable the fabrication of 3D living tissues comprised mammalian cells; and related technologies for preparing bio-inks and bioprinting multicellular tissues with complex architecture.